T. Rowe Price Associates
MJN

T. Rowe Price Associates’s Mead Johnson Nutrition Company MJN Stock Holding History

T. Rowe Price Associates’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,536,118
Closed -$226M – 2607
2017
Q1 		$226M Buy
2,536,118
+346,455
+16% +$28.5M 0.04% 399
2016
Q4 		$155M Buy
2,189,663
+1,167,408
+114% +$87M 0.03% 477
2016
Q3 		$80.8M Buy
1,022,255
+8,596
+0.8% +$733K 0.02% 640
2016
Q2 		$92M Buy
1,013,659
+66,394
+7% +$5.62M 0.02% 595
2016
Q1 		$80.5M Buy
947,265
+357,998
+61% +$26.6M 0.02% 611
2015
Q4 		$46.5M Sell
589,267
-5,800
-1% -$457K 0.01% 790
2015
Q3 		$41.9M Sell
595,067
-125,210
-17% -$10.3M 0.01% 833
2015
Q2 		$65M Buy
720,277
+206,510
+40% +$19.9M 0.01% 747
2015
Q1 		$51.6M Buy
513,767
+44,395
+9% +$4.48M 0.01% 835
2014
Q4 		$47.2M Buy
469,372
+11,810
+3% +$1.18M 0.01% 861
2014
Q3 		$44M Buy
457,562
+13,600
+3% +$1.29M 0.01% 876
2014
Q2 		$41.4M Sell
443,962
-1,800
-0.4% -$157K 0.01% 922
2014
Q1 		$37.1M Buy
445,762
+19,400
+5% +$1.57M 0.01% 946
2013
Q4 		$35.7M Buy
426,362
+6,690
+2% +$545K 0.01% 940
2013
Q3 		$31.2M Buy
419,672
+1,910
+0.5% +$143K 0.01% 966
2013
Q2 		$33.1M Buy
+417,762
New +$33.5M 0.01% 926

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

T. Rowe Price Associates's MJN Position: Q2 2017 in Review

T. Rowe Price Associates sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 2,536,118 shares — an estimated $226M sold.

T. Rowe Price Associates first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $226M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • T. Rowe Price Associates reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • T. Rowe Price Associates sold 2,536,118 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $226M.
  • T. Rowe Price Associates first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • T. Rowe Price Associates's Mead Johnson Nutrition Company position peaked at $226M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on T. Rowe Price Associates's 13F filing for Q2 2017, filed 14 Aug 2017.